News | Magnetic Resonance Imaging (MRI) | January 26, 2024

InkSpace Imaging gets FDA clearance for its Siemens 3T MRI compatible Small body array 

InkSpace Imaging gets FDA clearance for its Siemens 3T MRI compatible Small body array

January 26, 2024 — InkSpace Imaging, a leader in innovative diagnostic medical device technology, is proud to announce it received FDA clearance for its next-generation Small Body Array for the Siemens Healthineers Magnetom Skyra and Vida series 3T MRI scanners. This new medical device is part of their industry-leading suite of MR coils designed to revolutionize the patient experience while enhancing efficiency in MRI scans and clinical diagnosis. 

The technologically advanced Small Body Array is huggable, lightweight, and flexible. It wraps around patients like a blanket, ensuring unparalleled image quality. The body contouring design optimizes the signal-to-noise ratio, which is crucial for detecting subtle abnormalities often missed by standard rigid, conventional coils. This leap in image quality means quicker and more accurate diagnoses, especially in complex cases. 

This design marks a dramatic shift from conventional coils, as InkSpace Imaging's coils are up to 80 percent lighter and provide a 10-40% faster throughput. The design of the Small Body Array is especially noteworthy for its flexibility which allows it to conform to a wide,e range of patient anatomies and sizes, significantly reducing scan times and minimizing the duration patients need to remain still. This adaptability ensures all patients receive optimal imaging experiences, enhanced patient comfort, and significantly benefits technologists by streamlining the imaging process due to its high coil element density. 

Dr. Peter Fischer, CEO of InkSpace Imaging, stated: "The FDA clearance of InkSpace Imaging's Small Body Array marks a pivotal moment in MRI technology advancement. Our suite of MR coils is a game-changer, offering total freedom in coil positioning and handling. What's truly impressive is how our thin flexible coil contours to each patient's body, offering comfort while enhancing image quality. It's a win-win for patients and healthcare providers alike." 

The FDA clearance of InkSpace Imaging's Small Body Array is a testament to the company's commitment to innovation and improving patient care. This breakthrough technology again sets a new standard in MRI imaging. 


Related Content

News | Magnetic Resonance Imaging (MRI)

May 28, 2026 — Royal Philips and the Walt Disney Company have announced that Disney animated characters and stories are ...

Time May 28, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Radiology Imaging

May 18, 2026 — DICO, a company specializing in the creation of distributed diagnostic infrastructure for radiology, has ...

Time May 19, 2026
arrow
News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 11, 2026 – At the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE ...

Time May 11, 2026
arrow
News | Computed Tomography (CT)

April 23, 2026 — Royal Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...

Time April 30, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
Subscribe Now